ALTA BIOPHARMA PARTNERS II LP's Net Worth

$180 Million

Estimate Recalculated Dec 4, 2025 01:11AM EST

Who is ALTA BIOPHARMA PARTNERS II LP

ALTA BIOPHARMA PARTNERS II LP has an estimated net worth of $180 Million. This is based on reported shares across multiple companies, which include RENOVIS INC, CORCEPT THERAPEUTICS INC, RIGEL PHARMACEUTICALS INC, SCYNEXIS INC, and INTARCIA THERAPEUTICS, INC.

SEC CIK

ALTA BIOPHARMA PARTNERS II LP's CIK is 0001163156

Past Insider Trading and Trends

2014 was ALTA BIOPHARMA PARTNERS II LP's most active year for acquiring shares with 7 total transactions. ALTA BIOPHARMA PARTNERS II LP's most active month to acquire stocks was the month of April. 2014 was ALTA BIOPHARMA PARTNERS II LP's most active year for disposing of shares, totalling 6 transactions. ALTA BIOPHARMA PARTNERS II LP's most active month to dispose stocks was the month of April. 2014 saw ALTA BIOPHARMA PARTNERS II LP paying a total of $8,698,971.20 for 1,240,575 shares, this is the most they've acquired in one year. In 2014 ALTA BIOPHARMA PARTNERS II LP cashed out on 3,103,906 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RENOVIS INC

Investor
Updated Aug 09, 2005
Form 4
-42.00%
-500.00K
Aug 09, 2005
690.48K
Disposition
Aug 08
Form 4
-77.78%
-7.58M
Feb 11, 2004
2.17M
Options
Feb 10
Form 3
Feb 04, 2004
Showing 3 results

CORCEPT THERAPEUTICS INC

Investor
Updated Oct 20, 2009
Form 4/A
8.08%
472.03K
$0.75
$497.82K
Oct 20, 2009
6.32M
Purchase
Oct 16
Form 4
8.08%
472.03K
$0.75
$497.82K
Oct 20, 2009
6.32M
Purchase
Oct 16
Form 4
2.01%
104.83K
$1.45
$152.00K
Nov 13, 2008
5.31M
Grant
Nov 11
Form 4
38.28%
1.59M
$1.45
$3.00M
Mar 26, 2008
5.74M
Purchase
Mar 25
Form 3
Aug 20, 2007
4.15M
Showing 5 results

RIGEL PHARMACEUTICALS INC

Investor
Updated Aug 24, 2004
Form 4
-48.20%
-779.23K
$21.11
-$16.45M
Aug 24, 2004
837.50K
Disposition
Aug 20
Form 4
-0.85%
-3.10K
$21.50
-$66.65K
May 10, 2004
1.62M
Sale
May 07
Form 4
-20.75%
-95.20K
$21.31
-$2.03M
May 04, 2004
1.62M
Sale
May 03
Form 4
-1.80%
-8.40K
$21.25
-$178.50K
Apr 30, 2004
1.72M
Sale
Apr 30
Form 4
-4.23%
-42.80K
$21.25
-$909.51K
Apr 30, 2004
2.23M
Sale
Apr 28 - Apr 29
Form 4
-0.86%
-8.90K
$21.26
-$189.18K
Apr 28, 2004
2.28M
Sale
Apr 26 - Apr 27
Form 4
-2.46%
-13.10K
$21.32
-$279.29K
Apr 23, 2004
1.78M
Sale
Apr 23
Form 4
-0.82%
-8.80K
$21.26
-$187.12K
Apr 23, 2004
2.32M
Sale
Apr 21 - Apr 22
Form 4
-10.03%
-60.30K
$21.00
-$1.27M
Apr 08, 2004
1.80M
Sale
Apr 07
Form 4
-0.89%
-10.90K
$21.98
-$231.24K
Apr 07, 2004
2.47M
Sale
Apr 05 - Apr 06
Form 4
-1.21%
-7.49K
$20.00
-$149.74K
Mar 26, 2004
1.87M
Sale
Mar 24
Form 4/A
-10.73%
-74.46K
$20.00
-$1.49M
Mar 26, 2004
1.88M
Sale
Feb 19
Form 4
-16.10%
-111.70K
$20.00
-$2.23M
Feb 23, 2004
1.84M
Sale
Feb 19
Showing 13 results

SCYNEXIS INC

Investor
Updated May 08, 2014
Form 4
-60.05%
-1.93M
$9.06
May 08, 2014
1.29M
Buy-Options
May 07
Form 3
May 02, 2014
Showing 2 results

INTARCIA THERAPEUTICS, INC

Investor
Updated Sep 20, 2005
Form 3
Sep 20, 2005
Showing 1 results